Open AccessThe Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients
Author(s) -
Xian Wu,
Chaoran Ye,
Xingmeng Wang,
Ruyu Cai,
Junzhe Yang,
Xiafei Yu,
Yi Zhou,
Li Shen,
Yanhui Zhu,
Xiaoan Liu
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s284638
Subject(s) - epirubicin , docetaxel , medicine , cyclophosphamide , chemotherapy , gastroenterology , toxicity , paclitaxel , breast cancer , creatinine , oncology , urology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom